Liu He-Kun, Li Xue-Fei, Zhang Si-Zhong, Ren Yan, Liu Yun-Qiang, Wang Chun-Ting, Chen Xiang, Hu Yao-Min, Zhang Li
Department of Medical Genetics, West China Hospital, Sichuan University, the State Key Laboratory of Biotherapy of Human Disease, Chengdu 610041, China.
Yi Chuan Xue Bao. 2005 Jan;32(1):11-8.
Several independent population studies have reported that the apolipoprotein C3 (APOC3) Sst I polymorphism in apolipoprotein (apo) A1 /C3/A4/A5 gene cluster is associated with Hypertriglyceridaemia (HTG). HTG is a known risk factor for coronary atherosclerotic heart disease(CHD)and type II diabetes mellitus (non-insulin-dependent diabetes, NIDDM). The aim of this study is to investigate the association between the APOC3 gene Sst I polymorphism and the hypertriglyceridaemia in CHD and NIDDM in Chinese population. The genotype and allele frequencies of APOC3 Sst I polymorphism (S1/S2) were analyzed by PCR-restriction fragment length polymorphism in 267 CHD patients, 246 NIDDM patients and 491 unrelated healthy control individuals. The frequencies of minor allele 52 in CHD group, NIDDM group and control group were 0.301, 0.307 and 0.286, respectively. Compared with controls, there was no significant difference in distribution of genotype and allele frequencies of Sst I polymorphic site in CHD patients and NIDDM patients, respectively. However, the frequency of S1 S2 genotype in the HTG subgroup was significantly higher than that of the normal triglyceridaemia subgroup (NTG) in CHD patients (0.542 > 0.357, chi2 = 8.77, P = 0.0124). In NIDDM patients, the frequency of S2 S2 genotype in the HTG subgroup was significantly high, compared with that in the NTG subgroup (0.200 > 0.055, chi2 = 20.21, P = 0.0000), and there was significantly difference in the distribution of allele frequencies in subgroups of NTG and HTG (chi2 = 19.86, P = 0.0000). The level of triglyceride (TG) in S1 S2 genotype patients of CHD group were higher than that of S1 S1 genotype patients (P = 0.036). In NIDDM and controls groups, S2 S2 genotype individuals exhibited a significant increase in plasma TG concentrations, respectively compared with S1 S1 and S1 S2 genotype individuals of each group (P < 0.01). The minor allele S2, which was associated with both CHD with HTG and NIDDM with HTG and may contribute to the susceptibility of hypertriglyceridemia in CHD and NIDDM patients, may be one of the genetic predispositions to both CHD with HTG and NIDDM with HTG in Chinese population.
多项独立的人群研究报告称,载脂蛋白(apo)A1/C3/A4/A5基因簇中的载脂蛋白C3(APOC3)Sst I多态性与高甘油三酯血症(HTG)相关。HTG是冠状动脉粥样硬化性心脏病(CHD)和II型糖尿病(非胰岛素依赖型糖尿病,NIDDM)的已知危险因素。本研究的目的是调查中国人群中APOC3基因Sst I多态性与CHD和NIDDM患者高甘油三酯血症之间的关联。采用聚合酶链反应-限制性片段长度多态性方法分析了267例CHD患者、246例NIDDM患者和491例无亲缘关系的健康对照个体中APOC3 Sst I多态性(S1/S2)的基因型和等位基因频率。CHD组、NIDDM组和对照组中次要等位基因S2的频率分别为0.301、0.307和0.286。与对照组相比,CHD患者和NIDDM患者Sst I多态性位点的基因型和等位基因频率分布无显著差异。然而,CHD患者中HTG亚组的S1 S2基因型频率显著高于正常甘油三酯血症亚组(NTG)(0.542>0.357,χ2 = 8.77,P = 0.0124)。在NIDDM患者中,HTG亚组的S2 S2基因型频率显著高于NTG亚组(0.200>0.055,χ2 = 20.21,P = 0.0000),NTG和HTG亚组的等位基因频率分布也有显著差异(χ2 = 19.86,P = 0.0000)。CHD组S1 S2基因型患者的甘油三酯(TG)水平高于S1 S1基因型患者(P = 0.036)。在NIDDM组和对照组中,S2 S2基因型个体的血浆TG浓度分别显著高于每组的S1 S1和S1 S2基因型个体(P<0.01)。次要等位基因S2与CHD合并HTG以及NIDDM合并HTG均相关,可能是中国人群中CHD合并HTG和NIDDM合并HTG易感性的遗传因素之一。